Has Howard Goodman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $42,518 in general payments to Howard Goodman, MD across 242 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Howard Goodman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Howard Goodman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Howard Goodman, MD

Gynecologic Oncology · West Palm Beach, FLNPI 1114926904

Payments from drug & device makers

$42,518in general payments, 2019–2025

Across 242 payments — averaging $175.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Takeda Pharmaceuticals U.S.A., Inc.$29K
AstraZeneca$9K
Johnson & Johnson$353
Seagen Inc.$346
GSK$252
Eisai Inc.$234
plus $3K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Takeda Pharmaceuticals U.S.A., Inc.	30	$28,593
AstraZeneca(2 entities)	25	$9,495
Johnson & Johnson(2 entities)	16	$353
Seagen Inc.	16	$346
GSK	14	$252
Eisai Inc.	10	$234
Merck	14	$232
Intuitive Surgical	4	$228
LSI Solutions Inc	2	$215
Genentech USA, Inc.	7	$185
Bayer	7	$159
Bristol Myers Squibb	8	$158
Davol Inc.	1	$148
Daiichi Sankyo Inc.	6	$146
Novartis	7	$129
Momentis Surgical Inc.	1	$109
Incyte Corporation	5	$104
Hologic Sales And Service, LLC	1	$99
Pharmacyclics LLC, An Abbvie Company	5	$96
Myriad Genetic Laboratories, Inc.	5	$90
Tempus AI, Inc	4	$86
Beigene USA, Inc.	3	$60
Dendreon Pharmaceuticals LLC	2	$57
Astellas Pharma US Inc	3	$54
Tersera Therapeutics LLC	2	$48
Sanofi	2	$43
Servier Pharmaceuticals LLC	2	$42
AbbVie	2	$42
Aurobindo Pharma USA, Inc.	2	$38
Lilly USA, LLC	2	$36
Ipsen Biopharmaceuticals, Inc	2	$35
Medtronic	1	$33
Taiho Oncology, Inc.	2	$32
Coherus Oncology, Inc.	1	$30
Sobi, Inc	2	$30
Immunogen, Inc.	1	$28
Janssen Scientific Affairs, LLC	1	$25
Sun Pharmaceutical Industries Inc.	1	$25
Deciphera Pharmaceuticals Inc.	1	$25
Sumitomo Pharma America, Inc.	1	$24
Azurity Pharmaceuticals, Inc.	1	$24
Springworks Therapeutics, Inc.	1	$22
Aspira Women's Health Inc	2	$22
Tesaro, Inc.	1	$21
Kyowa Kirin, Inc.	1	$21
Mylan Institutional Inc.	1	$20
EMD Serono, Inc.	1	$20
Helsinn Therapeutics (U.S.), Inc.	1	$19
Regeneron Healthcare Solutions, Inc.	1	$19
Sirtex Medical Inc	1	$18
E.r. Squibb & Sons, L.L.C.	1	$17
TG Therapeutics, Inc.	1	$17
Pfizer	1	$17
Exelixis Inc.	1	$16
Legend Biotech USA Inc.	1	$15
Recordati_rare_diseases_inc.	1	$15
Morphosys, US Inc.	1	$15
Stemline Therapeutics Inc.	1	$15
Agios Pharmaceuticals, Inc.	1	$14
Heron Therapeutics, Inc.	1	$9

How this compares

$42,518 in reported general payments places this provider in the 65th percentile of 117 gynecologic oncology providers in Florida.

See all gynecologic oncology providers in Florida →

Medicare billing

Part B allowed, 2024

$141,190

Medicare patients

268

Services billed

916

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gynecologic oncology in West Palm Beach

Bradley MonkWest Palm Beach$10.5M
Christopher McCannWest Palm Beach$32K
Matthew SchlumbrechtMiami$16.7M
Brian SlomovitzFort Lauderdale$13.9M
John DiazMiami$3.7M
Robert HollowayOrlando$3.1M
Robert WenhamTampa$2.9M
Hye Sook ChonTampa$2.4M
Beverly LongSarasota$1.9M
Martin MartinoJacksonville$1.3M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →